Loading…
Reported covered position: Amy Efantis, LD, Rep. Artur Davis
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Lake Tahoe Restoration Act of 2013
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Patent Settlements; Patent Trolls (H.R. 3390 - "Innovation Act")
Lake Tahoe Restoration Act of 2013
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Patent Settlements; Patent Trolls (H.R. 3390)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
Cost Sharing (Preserving Access to Medicines); CMS Proposed Rule (Protected Classes, etc.); "Hard to Obtain"; Risk Evaluation and Mitigation Strategies (REMS); Healthcare Exchanges
Transatlantic Trade & Investment Partnership (TTIP) - Proposed Free Trade Agreement between the European Union and the United States. (Market Access; Industry-Specific Regulation; Broader Rules and Principles and Modes of Co-operation)
Source: Senate LDA
Protecting Consumer Access to Generic Drugs Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Patent Settlements; H.R. 1706 (The Protecting Consumer Access to Generic Drugs Act of 2009) and S. 369 (The Preserve Access to Affordable Generics Act)
Preserve Access to Affordable Generics Act
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Patent Settlements; H.R. 1706 (The Protecting Consumer Access to Generic Drugs Act of 2009) and S. 369 (The Preserve Access to Affordable Generics Act)
Commercial Motor Vehicle Advanced Safety Technology Tax Act of 2011
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Patent Settlements; H.R. 1706 and S. 5369, Financial Services Appropriations Bill -- Senate; Patent Bill (S. 23/H.R. 1249 -- America Invests Act); False Marketing (H.R. 4954)
Commercial Motor Vehicle Advanced Safety Technology Tax Act of 2011
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Patent Settlements; H.R. 1706 and S. 5369
Commercial Motor Vehicle Advanced Safety Technology Tax Act of 2011
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Patent Settlements; H.R. 1706 and S. 5369
Commercial Motor Vehicle Advanced Safety Technology Tax Act of 2011
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Patent Settlements; H.R. 1706 and S. 5369; Senate; Patent Bill (S. 23/H.R. 1249 -- America Invests Act)
Commercial Motor Vehicle Advanced Safety Technology Tax Act of 2011
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Patent Settlements; H.R. 1706 and S. 5369; Senate; Patent Bill (S. 23/H.R. 1249 -- America Invests Act)
To suspend temporarily the duty on certain compression-ignition internal combustion piston engines.
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Patent Settlements; H.R. 1706 and S. 5369, Financial Services Appropriations Bill -- Senate; Patent Bill (S. 23/H.R. 1249 -- America Invests Act); False Marketing (H.R. 4954)
Protecting Consumer Access to Generic Drugs Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Patent Reform, Patent Settlements; H.R. 1706 and S. 5369
Protecting Consumer Access to Generic Drugs Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Patent reform, Patent settlements; H.R. 1706 and S. 5369
Protecting Consumer Access to Generic Drugs Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Patent Reform, Patent Settlements; H.R. 1706 and S. 5369, Financial Services Appropriations Bill - Senate
Protecting Consumer Access to Generic Drugs Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Patent Reform, Patent Settlements; H.R. 1706 and S. 5369, Financial Services Appropriations Bill - Senate
Protecting Consumer Access to Generic Drugs Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Patent Settlements; H.R. 1706 and S. 5369, Financial Services Appropriations Bill - Senate
Protecting Consumer Access to Generic Drugs Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Patent Reform; Patent Settlements; H.R. 1706 and S. 5369
Protecting Consumer Access to Generic Drugs Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Patent Settlements; H.R. 1706 and S. 5369, Financial Services Appropriations Bill - Senate
Protecting Consumer Access to Generic Drugs Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Patent Reform, Patent Settlements; H.R. 1706 and S. 5369
America's Affordable Health Choices Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Health care reform: America's Affordable Health Choices Act, HR 3200 (Education and Labor, Ways and Means, House Energy and Commerce committee drafts), Affordable Health Choices Act, and America's Healthy Future Act (S 1679: Senate HELP and S 1796: Senate Finance committee drafts); pricing/rebates, importation, coverage, comparative effectiveness, biosimilars, transparency; 340B pricing, Independent Patient Advisory Board; PPACA - Patient Protection and Affordable Care Act
America's Affordable Health Choices Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Health care reform: America's Affordable Health Choices Act, H.R. 3200 (Education and Labor, Ways and Means, House Energy and Commerce committee drafts), Affordable Health Choices Act, and America's Healthy Future Act (S. 1679: Senate HELP and S. 1796: Senate Finance committee drafts); pricing/rebates; importation; coverage; comparative effectiveness; biosimilars; transparency; 340B pricing; Independent Patient Advisory Board; PPACA - Patient Protection and Affordable Care Act
Affordable Health Choices Act
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Health care reform: America's Affordable Health Choices Act, HR 3200 (Education and Labor, Ways and Means, House Energy and Commerce committee drafts), Affordable Health Choices Act, and America's Healthy Future Act (S 1679: Senate HELP and S 1796: Senate Finance committee drafts); pricing/rebates, importation, coverage, comparative effectiveness, biosimilars, transparency; 340B pricing, Independent Patient Advisory Board; PPACA - Patient Protection and Affordable Care Act
Affordable Health Choices Act
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Health care reform: America's Affordable Health Choices Act, H.R. 3200 (Education and Labor, Ways and Means, House Energy and Commerce committee drafts), Affordable Health Choices Act, and America's Healthy Future Act (S. 1679: Senate HELP and S. 1796: Senate Finance committee drafts); pricing/rebates; importation; coverage; comparative effectiveness; biosimilars; transparency; 340B pricing; Independent Patient Advisory Board; PPACA - Patient Protection and Affordable Care Act
America's Healthy Future Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Health care reform: America's Affordable Health Choices Act, H.R. 3200 (Education and Labor, Ways and Means, House Energy and Commerce committee drafts), Affordable Health Choices Act, and America's Healthy Future Act (S. 1679: Senate HELP and S. 1796: Senate Finance committee drafts); pricing/rebates; importation; coverage; comparative effectiveness; biosimilars; transparency; 340B pricing; Independent Patient Advisory Board; PPACA - Patient Protection and Affordable Care Act
America's Healthy Future Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Health care reform: America's Affordable Health Choices Act, HR 3200 (Education and Labor, Ways and Means, House Energy and Commerce committee drafts), Affordable Health Choices Act, and America's Healthy Future Act (S 1679: Senate HELP and S 1796: Senate Finance committee drafts); pricing/rebates, importation, coverage, comparative effectiveness, biosimilars, transparency; 340B pricing, Independent Patient Advisory Board; PPACA - Patient Protection and Affordable Care Act
Setting forth the congressional budget for the United States Government for fiscal year 2010 and including the appropriate budgetary levels for fiscal years 2009 and 2011 through 2014.
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Health Reform HR.1 American Recovery and Reinvestment Act focusing on Comparative Effectiveness and Trade President's Budget (see details on page 3) House/Senate Budget - H. Con. Res.85 President's Budget including Medicaid Rebates, Medicare Part D, Follow-on Biologics, Importation, Import Safety, Comparative Effectiveness, Patent Settlements, Intellectual Property Reform and Research Tax Credit.
Setting forth the congressional budget for the United States Government for fiscal year 2010 and including the appropriate budgetary levels for fiscal years 2009 and 2011 through 2014.
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Health Reform HR.1 American Recovery and Reinvestment Act focusing on Comparative Effectiveness and Trade President's Budget (see details on page 3) House/Senate Budget - H. Con. Res.85 President's Budget including Medicaid Rebates, Medicare Part D, Follow-on Biologics, Importation, Import Safety, Comparative Effectiveness, Patent Settlements, Intellectual Property Reform and Research Tax Credit.
Employee Free Choice Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Employee Free Choice Act - monitoring status of bill HR 1409 and S 560
Employee Free Choice Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Employee Free Choice Act - monitoring status of bill HR 1409 and S 560
Home Office Deduction Simplification Act
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
H.R.1509, S.560 - Employee Free Choice Act
Home Office Deduction Simplification Act
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
H.R.1509, S.560 - Employee Free Choice Act
Protecting Consumer Access to Generic Drugs Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
S.515 - Patent Reform Act H.R.1706 - Patent Settlement bill
Protecting Consumer Access to Generic Drugs Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
patent reform, patent settlements; H.R. 1706 and S.5369
Protecting Consumer Access to Generic Drugs Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
S.515 - Patent Reform Act H.R.1706 - Patent Settlement bill
Protecting Consumer Access to Generic Drugs Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Patent reform, Patent settlements; H.R. 1706 and S. 5369
Protecting Consumer Access to Generic Drugs Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Patent reform, Patent settlements; H.R. 1706 and S. 5369
America's Affordable Health Choices Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Health care reform: America's Affordable Health Choices Act, HR 3200 (Education and Labor, Ways and Means, House Energy and Commerce committee drafts), Affordable Health Choices Act, and America's Healthy Future Act (S 1679: Senate HELP and S 1796: Senate Finance committee drafts); pricing/rebates, importation, coverage, comparative effectiveness, biosimilars, transparency
America's Affordable Health Choices Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Health care reform: America's Affordable Health Choices Act, HR 3200 (Education and Labor, Ways and Means, House Energy and Commerce committee drafts), Affordable Health Choices Act, and America's Healthy Future Act (S 1679: Senate HELP and S 1796: Senate Finance committee drafts); pricing/rebates, importation, coverage, comparative effectiveness, biosimilars, transparency
American Recovery and Reinvestment Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Health care reform: (Affordable Health Choices Act), coverage,comparative effectiveness, pricing, rebates, bio-similars; Stimulus bill(s): American Recovery and Reinvestment Act - health IT and comparative effectiveness (HR 1 and S. 1)
Affordable Health Choices Act
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Health care reform: America's Affordable Health Choices Act, HR 3200 (Education and Labor, Ways and Means, House Energy and Commerce committee drafts), Affordable Health Choices Act, and America's Healthy Future Act (S 1679: Senate HELP and S 1796: Senate Finance committee drafts); pricing/rebates, importation, coverage, comparative effectiveness, biosimilars, transparency
Affordable Health Choices Act
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Health care reform: America's Affordable Health Choices Act, HR 3200 (Education and Labor, Ways and Means, House Energy and Commerce committee drafts), Affordable Health Choices Act, and America's Healthy Future Act (S 1679: Senate HELP and S 1796: Senate Finance committee drafts); pricing/rebates, importation, coverage, comparative effectiveness, biosimilars, transparency
America's Healthy Future Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Health care reform: America's Affordable Health Choices Act, HR 3200 (Education and Labor, Ways and Means, House Energy and Commerce committee drafts), Affordable Health Choices Act, and America's Healthy Future Act (S 1679: Senate HELP and S 1796: Senate Finance committee drafts); pricing/rebates, importation, coverage, comparative effectiveness, biosimilars, transparency
America's Healthy Future Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Health care reform: America's Affordable Health Choices Act, HR 3200 (Education and Labor, Ways and Means, House Energy and Commerce committee drafts), Affordable Health Choices Act, and America's Healthy Future Act (S 1679: Senate HELP and S 1796: Senate Finance committee drafts); pricing/rebates, importation, coverage, comparative effectiveness, biosimilars, transparency
Patent Reform Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
S.515 - Patent Reform Act H.R.1706 - Patent Settlement bill
Patent Reform Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
S.515 - Patent Reform Act H.R.1706 - Patent Settlement bill
Employee Free Choice Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Employee Free Choice Act - monitoring status of bill HR 1409 and S 560
Employee Free Choice Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
H.R.1509, S.560 - Employee Free Choice Act
Employee Free Choice Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Employee Free Choice Act - monitoring status of bill HR 1409 and S 560
Employee Free Choice Act of 2009
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
H.R.1509, S.560 - Employee Free Choice Act
Patent Reform Act of 2007
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
S. 1145, Patent Reform Act of 2007 HR. 1908, Patent Reform Act of 2007
Patent Reform Act of 2007
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
S. 1145, Patent Reform Act of 2007 H.R. 1908, Patent Reform Act of 2007
Food and Drug Import Safety Act of 2007
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
H.R. 477 & S. 999, Stop Stroke Act S. 2029 & H.R. 5605, Physicians Payments Sunshine Act of 2007 H.R. 3610, Food and Drug Import Safety Act H.R. 5839, Safeguarding America's Pharmaceuticals Act and to amend the Federal Food, Drug and Cosmetic Act to improve the safety of drugs S. 2731, Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008.
Fair Medicaid Drug Payment Act of 2007
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
HR. 3162, Children's Health and Medicare Protection Act of 2007 S.3101, Medicare Improvements for Patients and Providers Act of 2008 S.3118, Preserving Access to Medicare Act of 2008 HR.6331, Medicare Improvements for Patients and Providers Act of 2008 S.1951 & H.R. 3700, Fair Medicaid Drug Payment Act of 2007
Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Medicare Part D Pricing S.2408 & H.R. 4296, Medicare Electronic Medication and Safety Protection Act of 2007 H.R.6331, Medicare Improvements for Patients and Providers Act of 2008
Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Medicare Part D Pricing S. 2408 & H.R. 4296, Medicare Electronic Medication and Safety Protection Act of 2007 H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008
To suspend temporarily the duty on Cyclopropylaminonicotinic acid.
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
H.R. 4677, Relating to duty suspension of cyclopropylaminonicotine acid; The Farm Bill (amendments to Lacey Act)
To suspend temporarily the duty on Cyclopropylaminonicotinic acid.
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
H.R.4677, Relating to duty suspension of cyclopropylaminonicotine acid; The Farm Bill (amendments to Lacey Act)
To suspend temporarily the duty on Cyclopropylaminonicotinic acid.
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
H.R. 4677, relating to Duty Suspension of Cyclopropylaminonicotine acid
Stroke Treatment and Ongoing Prevention Act
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
H.R. 477 & S. 999, Stop Stroke Act S. 2029 & H.R. 5605, Physicians Payments Sunshine Act of 2007 H.R. 3610, Food and Drug Import Safety Act H.R. 5839, Safeguarding America's Pharmaceuticals Act and to amend the Federal Food, Drug and Cosmetic Act to improve the safety of drugs S. 2731, Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008.
False Claims Act Correction Act of 2007
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
The False Claims Act S. 2041 & HR 4854
Physician Payments Sunshine Act of 2008
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
H.R. 477 & S. 999, Stop Stroke Act S. 2029 & H.R. 5605, Physicians Payments Sunshine Act of 2007 H.R. 3610, Food and Drug Import Safety Act H.R. 5839, Safeguarding America's Pharmaceuticals Act and to amend the Federal Food, Drug and Cosmetic Act to improve the safety of drugs S. 2731, Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008.
Physician Payments Sunshine Act of 2008
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
S. 2029 and H.R. 5605 - Physician Payments Sunshine Act of 2007
Safeguarding America's Pharmaceuticals Act of 2008
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
H.R. 477 & S. 999, Stop Stroke Act S. 2029 & H.R. 5605, Physicians Payments Sunshine Act of 2007 H.R. 3610, Food and Drug Import Safety Act H.R. 5839, Safeguarding America's Pharmaceuticals Act and to amend the Federal Food, Drug and Cosmetic Act to improve the safety of drugs S. 2731, Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008.
Medicare Improvements for Patients and Providers Act of 2008
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
HR. 3162, Children's Health and Medicare Protection Act of 2007 S.3101, Medicare Improvements for Patients and Providers Act of 2008 S.3118, Preserving Access to Medicare Act of 2008 HR.6331, Medicare Improvements for Patients and Providers Act of 2008 S.1951 & H.R. 3700, Fair Medicaid Drug Payment Act of 2007
Medicare Improvements for Patients and Providers Act of 2008
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Medicare Part D Pricing S. 2408 & H.R. 4296, Medicare Electronic Medication and Safety Protection Act of 2007 H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008
Medicare Improvements for Patients and Providers Act of 2008
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Medicare Part D Pricing S.2408 & H.R. 4296, Medicare Electronic Medication and Safety Protection Act of 2007 H.R.6331, Medicare Improvements for Patients and Providers Act of 2008
Patent Reform Act of 2007
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
S. 1145, Patent Reform Act of 2007 HR. 1908, Patent Reform Act of 2007
Patent Reform Act of 2007
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
S. 1145, Patent Reform Act of 2007 H.R. 1908, Patent Reform Act of 2007
Fair Medicaid Drug Payment Act of 2007
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
HR. 3162, Children's Health and Medicare Protection Act of 2007 S.3101, Medicare Improvements for Patients and Providers Act of 2008 S.3118, Preserving Access to Medicare Act of 2008 HR.6331, Medicare Improvements for Patients and Providers Act of 2008 S.1951 & H.R. 3700, Fair Medicaid Drug Payment Act of 2007
Physician Payments Sunshine Act of 2007
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
S. 2029 and H.R. 5605 - Physician Payments Sunshine Act of 2007
Physician Payments Sunshine Act of 2007
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
H.R. 477 & S. 999, Stop Stroke Act S. 2029 & H.R. 5605, Physicians Payments Sunshine Act of 2007 H.R. 3610, Food and Drug Import Safety Act H.R. 5839, Safeguarding America's Pharmaceuticals Act and to amend the Federal Food, Drug and Cosmetic Act to improve the safety of drugs S. 2731, Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008.
False Claims Act Correction Act of 2008
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
The False Claims Act S. 2041 & HR 4854
Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Medicare Part D Pricing S. 2408 & H.R. 4296, Medicare Electronic Medication and Safety Protection Act of 2007 H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008
Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
Medicare Part D Pricing S.2408 & H.R. 4296, Medicare Electronic Medication and Safety Protection Act of 2007 H.R.6331, Medicare Improvements for Patients and Providers Act of 2008
Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
H.R. 477 & S. 999, Stop Stroke Act S. 2029 & H.R. 5605, Physicians Payments Sunshine Act of 2007 H.R. 3610, Food and Drug Import Safety Act H.R. 5839, Safeguarding America's Pharmaceuticals Act and to amend the Federal Food, Drug and Cosmetic Act to improve the safety of drugs S. 2731, Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008.
Medicare Improvements for Patients and Providers Act of 2008
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
HR. 3162, Children's Health and Medicare Protection Act of 2007 S.3101, Medicare Improvements for Patients and Providers Act of 2008 S.3118, Preserving Access to Medicare Act of 2008 HR.6331, Medicare Improvements for Patients and Providers Act of 2008 S.1951 & H.R. 3700, Fair Medicaid Drug Payment Act of 2007
Preserving Access to Medicare Act of 2008
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
HR. 3162, Children's Health and Medicare Protection Act of 2007 S.3101, Medicare Improvements for Patients and Providers Act of 2008 S.3118, Preserving Access to Medicare Act of 2008 HR.6331, Medicare Improvements for Patients and Providers Act of 2008 S.1951 & H.R. 3700, Fair Medicaid Drug Payment Act of 2007
Stroke Treatment and Ongoing Prevention Act of 2008
Client: BOEHRINGER INGELHEIM USA CORPORATION · Firm: BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
H.R. 477 & S. 999, Stop Stroke Act S. 2029 & H.R. 5605, Physicians Payments Sunshine Act of 2007 H.R. 3610, Food and Drug Import Safety Act H.R. 5839, Safeguarding America's Pharmaceuticals Act and to amend the Federal Food, Drug and Cosmetic Act to improve the safety of drugs S. 2731, Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008.
Food and Drug Administration Safety & Innovation Act (FDASIA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Transatlantic Trade & Investment Partnership (TTIP)
Patent Settlements; Patent Trolls (H.R. 3390 - "Innovation Act")
Food and Drug Administration Safety & Innovationi Act (FDASIA) - Updates/Implementation
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Patent Settlements; Patent Trolls (H.R. 3390)
Transatlantic Trade & Investment Partnership (TTIP)
Food and Drug Administration Safety & Innovation Act (FDASIA) - Updates
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Food and Drug Administration Safety & Innovation Act (FDASIA) - Updates
Patent Settlements
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Patent Settlements
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Patent Settlements
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Drug Shortages; The Preserving Access to Life Saving Medicines Act (S. 296)
Patent Settlements
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Patent Settlements
Drug Shortages; The Preserving Access to Life Saving Medicines Act (S. 296)
Health Care Reform; Pricing/Rebates; Importation; Coverage; Independent Patient Advisory Board
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Patent Settlements
Gain Act; Shortages; Supply Chain Security; Best Pharmaceuticals for Children Act/Pediatric Research Equity Act Reauthorization; Risk Evaluation and Mitigation Strategies (REMS); Generic Drug User Fee Act; Prescription Drug User Fee Act
Drug Shortages; The Preserving Access to Life Savings Medicines Act (s. 296)
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Patent Settlements; H.R. 1706 (The Protecting Consumer Access to Generic Drugs Act of 2009) and S. 369 (The Preserve Access to Affordable Generics Act)
Health Care Reform; Pricing/Rebates; Importation; Coverage; Independent Patient Advisory Board
Drug Shortages; The Preserving Access to Life Savings Medicines Act (S. 296)
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Drug Shortages; The Preserving Access to Life Savings Medicines Act (S. 296)
Patent Settlements; H.R. 1706 and S. 5369
Health Care Reform; Pricing/Rebates; Importation; Coverage; Independent Patient Advisory Board
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Drug Shortages; The Preserving Access to Life Savings Medicines Act (S. 296)
Patent Settlements; H.R. 1706 and S. 5369
Health Care Reform; Pricing/Rebates; Importation; Coverage; Independent Patient Advisory Board
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Patent Settlements; H.R. 1706 and S. 5369; Senate; Patent Bill (S. 23/H.R. 1249 -- America Invests Act)
Reauthorization of the Prescription Drug User Fee Act; Drug Safety
Health Care Reform; Patent and Affordable Care Act implementation - pricing/rebates; importation; coverage; Independent Patient Advisory Board
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Patent Settlements; H.R. 1706 and S. 5369; Senate; Patent Bill (S. 23/H.R. 1249 -- America Invests Act)
Health care reform; Patent and Affordable Care Act implementation - pricing/rebates; importation; coverage; Independent Patient Advisory Board; drug shortages; The Preserving Access to Life Saving Medicines Act (S.296)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Patent Settlements; H.R. 1706 and S. 5369, Financial Services Appropriations Bill -- Senate; Patent Bill (S. 23/H.R. 1249 -- America Invests Act); False Marketing (H.R. 4954)
Health care reform; Patient Protection and Affordable Care Act implementation - pricing/rebates; importation; coverage; comparative effectiveness; Independent Patient Advisory Board; drug shortages; The Preserving Access to Life Saving Medicines Act (S. 296)
340B (Medicaid) Expansion
Discussion with Chief Medical Officer -- Afibrulation
Patent Reform, Patent Settlements; H.R. 1706 and S. 5369, Financial Services Appropriations Bill - Senate
340B (Medicaid) Expansion
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
340B (Medicaid) Expansion
Patent Reform; Patent Settlements; H.R. 1706 and S. 5369
Health care reform; Patient Protection and Affordable Care Act implementation - pricing/rebates; importation; coverage; comparative effectiveness; biosimilars; transparency; 340B pricing; Independent Patient Advisory Board; Prescription Drug User Fee Act Reauthorization
Health care reform: America's Affordable Health Choices Act, H.R. 3200 (Education and Labor, Ways and Means, House Energy and Commerce committee drafts), Affordable Health Choices Act, and America's Healthy Future Act (S. 1679: Senate HELP and S. 1796: Senate Finance committee drafts); pricing/rebates; importation; coverage; comparative effectiveness; biosimilars; transparency; 340B pricing; Independent Patient Advisory Board; PPACA - Patient Protection and Affordable Care Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Health care reform; Patient Protection and Affordable Care Act implementation - pricing/rebates, importation, coverage, comparative effectiveness; biosimilars, transparency; 340B pricing, Independent Patient Advisory Board
Patent Settlements; H.R. 1706 and S. 5369, Financial Services Appropriations Bill - Senate
340B (Medicaid) Expansion
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Health care reform; Patient Protection and Affordable Care Act implementation - pricing/rebates, importation, coverage, comparative effectiveness; biosimilars, transparency; 340B pricing, Independent Patient Advisory Board
Patent Settlements; H.R. 1706 and S. 5369, Financial Services Appropriations Bill - Senate
340B (Medicaid) Expansion
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Health care reform: Patient Protection and Affordable Care Act implementation - pricing/rebates, importation, coverage, comparative effectiveness; biosimilars, transparency; 340B pricing, Independent Patient Advisory Board; Prescription Drug User Fee Reauthorization
Patent Reform, Patent Settlements; H.R. 1706 and S. 5369, Financial Services Appropriations Bill - Senate
340B (Medicaid) Expansion
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Patent Reform, Patent Settlements; H.R. 1706 and S. 5369
Health care reform: Patient Protection and Affordable Care Act implementation - pricing/rebates, importation, coverage, comparative effectiveness, biosimilars, transparency; 340B pricing, Independent Patient Advisory Board; Prescription Drug User Free Act Reauthorization
Supplemental Appropriations Bill - patent settlements (no bill number at this stage)
340B (Medicaid) Expansion
Supplemental Appropriations Bill - patent settlements (no bill number at this stage)
Health care reform: Patient Protection and Affordable Care Act implementation - pricing/rebates, importation, coverage, comparative effectiveness, biosimilars, transparency; 340B pricing, Independent Patient Advisory Board; Prescription Drug User Free Act Reauthorization
Patent reform, Patent settlements; H.R. 1706 and S. 5369
Health care reform: America's Affordable Health Choices Act, HR 3200 (Education and Labor, Ways and Means, House Energy and Commerce committee drafts), Affordable Health Choices Act, and America's Healthy Future Act (S 1679: Senate HELP and S 1796: Senate Finance committee drafts); pricing/rebates, importation, coverage, comparative effectiveness, biosimilars, transparency; 340B pricing, Independent Patient Advisory Board; PPACA - Patient Protection and Affordable Care Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Employee Free Choice Act - monitoring status of bill HR 1409 and S 560
Miscellaneous Tariff Bill; relating to the duty suspension of cyclopropylaminonicotine acid
Health care reform: America's Affordable Health Choices Act, HR 3200 (Education and Labor, Ways and Means, House Energy and Commerce committee drafts), Affordable Health Choices Act, and America's Healthy Future Act (S 1679: Senate HELP and S 1796: Senate Finance committee drafts); pricing/rebates, importation, coverage, comparative effectiveness, biosimilars, transparency
Health care reform: America's Affordable Health Choices Act, HR 3200 (Education and Labor, Ways and Means, House Energy and Commerce committee drafts), Affordable Health Choices Act, and America's Healthy Future Act (S 1679: Senate HELP and S 1796: Senate Finance committee drafts); pricing/rebates, importation, coverage, comparative effectiveness, biosimilars, transparency
Miscellaneous Trade bill; relating to the duty suspension of cyclopropylaminonicotine acid
Health care reform: (Affordable Health Choices Act), coverage,comparative effectiveness, pricing, rebates, bio-similars; Stimulus bill(s): American Recovery and Reinvestment Act - health IT and comparative effectiveness (HR 1 and S. 1)
patent reform, patent settlements; H.R. 1706 and S.5369
Employee Free Choice Act
H.R.1509, S.560 - Employee Free Choice Act
S.515 - Patent Reform Act H.R.1706 - Patent Settlement bill
Health Reform HR.1 American Recovery and Reinvestment Act focusing on Comparative Effectiveness and Trade President's Budget (see details on page 3) House/Senate Budget - H. Con. Res.85 President's Budget including Medicaid Rebates, Medicare Part D, Follow-on Biologics, Importation, Import Safety, Comparative Effectiveness, Patent Settlements, Intellectual Property Reform and Research Tax Credit.
S.515 - Patent Reform Act H.R.1706 - Patent Settlement bill
H.R.1509, S.560 - Employee Free Choice Act
Health Reform HR.1 American Recovery and Reinvestment Act focusing on Comparative Effectiveness and Trade President's Budget (see details on page 3) House/Senate Budget - H. Con. Res.85 President's Budget including Medicaid Rebates, Medicare Part D, Follow-on Biologics, Importation, Import Safety, Comparative Effectiveness, Patent Settlements, Intellectual Property Reform and Research Tax Credit.
H.R.4677, Relating to duty suspension of cyclopropylaminonicotine acid; The Farm Bill (amendments to Lacey Act)
Protocol Amending the Convention Between the United States of America and Canada with Respect to Taxes on Income and on Capital (Treaty Doc. 110-15); The Bailout (R&D Tax Credit)
Medicare Part D Pricing S.2408 & H.R. 4296, Medicare Electronic Medication and Safety Protection Act of 2007 H.R.6331, Medicare Improvements for Patients and Providers Act of 2008
H.R. 4677, Relating to duty suspension of cyclopropylaminonicotine acid; The Farm Bill (amendments to Lacey Act)
Protocol Amending the Convention Between the United States of America and Canada with Respect to Taxes on Income and on Capital (Treaty Doc. 110-15); The Bailout (R&D Tax Credit)
Medicare Part D Pricing S. 2408 & H.R. 4296, Medicare Electronic Medication and Safety Protection Act of 2007 H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008
HR. 1585, National Defense Authorization Act for Fiscal Year 2008.
HR. 3162, Children's Health and Medicare Protection Act of 2007 S.3101, Medicare Improvements for Patients and Providers Act of 2008 S.3118, Preserving Access to Medicare Act of 2008 HR.6331, Medicare Improvements for Patients and Providers Act of 2008 S.1951 & H.R. 3700, Fair Medicaid Drug Payment Act of 2007
The False Claims Act S. 2041 & HR 4854
S. 1145, Patent Reform Act of 2007 HR. 1908, Patent Reform Act of 2007
S. 2029 and H.R. 5605 - Physician Payments Sunshine Act of 2007
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Supplimentatl Appropriations Bill - patent settlements (no bill number at this stage)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B (Medicaid) Expansion
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Patent Reform, Patent Settlements; H.R. 1706 and S. 5369
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Medicare Part D preservation in health reform Rebates, Medicare, Medicaid and Medicaid expansion in health reform
Patent reform, Patent settlements; H.R. 1706 and S. 5369
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Employee Free Choice Act - monitoring status of bill HR 1409 and S 560
Patent reform, Patent settlements; H.R. 1706 and S. 5369
Medicare Part D preservation in health reform Rebates, Medicare, Medicaid and Medicaid expansion in health reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Miscellaneous Trade bill; relating to the duty suspension of cyclopropylaminonicotine acid; The Farm bill (amendment to Lacey Act)
Medicare Part D preservation in health reform Rebates, Medicare, Medicaid and Medicaid expansion in health reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 477 & S. 999, Stop Stroke Act S. 2029 & H.R. 5605, Physicians Payments Sunshine Act of 2007 H.R. 3610, Food and Drug Import Safety Act H.R. 5839, Safeguarding America's Pharmaceuticals Act and to amend the Federal Food, Drug and Cosmetic Act to improve the safety of drugs S. 2731, Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008.
Reauthorization of the Animal Drug User Fee Act, no specific legislation
H.R. 4677, relating to Duty Suspension of Cyclopropylaminonicotine acid
Issues related to tariffs HS.4677, To suspend temporarily the dute on Cyclopropylaminonicotinic acid US-Canadian Tax Treaty
S. 1145, Patent Reform Act of 2007 H.R. 1908, Patent Reform Act of 2007
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of